Can BCIs enlighten the concept of agency? A plea for an experimental philosophy of neurotechnology
Cham : Springer
InFriedrich, O.; Wolkenstein, A.; Bublitz, C. (ed.), Clinical neurotechnology meets artificial intelligence: Philosophical, ethical, legal and social implications, pp. 55-68
Part of book or chapter of book
Display more detailsDisplay less details
SW OZ DCC AI
Friedrich, O.; Wolkenstein, A.; Bublitz, C. (ed.), Clinical neurotechnology meets artificial intelligence: Philosophical, ethical, legal and social implications
SubjectCognitive artificial intelligence
Passive BCIs can be used to measure brain processes that take place without necessarily having the intention to communicate, or even while being unaware that specific information about mental states is being collected. This type of symbiotic neurotechnology has the potential to create new and philosophically fascinating cases where the question of "was that me?" will make sense from both an individual and a societal perspective. We think that symbiotic technology is philosophically interesting in that it enables subconscious brain states to influence actions in a new, technology-mediated way. We will examine some of these cases and make a plea for a more systematic use of symbiotic technology in experimentally guided thought experiments aimed at studying the sense of agency. Our guiding questions are: What could technology-induced agency confusions tell us about the experience of ownership of action? What theoretical (e.g., conceptual) and practical implications (e.g., related to identity and responsibility) might this have?
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.